Загрузка...
Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses
Oncolytic viruses (OVs) preferentially infect and kill cancer cells. Additionally, OV-induced immune responses subvert cancer-associated immunosuppression and promote antitumor immunity. We have recently demonstrated that the complementation of oncolytic virotherapy with gemcitabine accentuates its...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Landes Bioscience
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4010537/ https://ncbi.nlm.nih.gov/pubmed/24804161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.27622 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|